Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A05 BILE AND LIVER THERAPY
A05A BILE THERAPY
A05AA Bile acids and derivatives
A05AA02 Ursodeoxycholic acid
D00734 Ursodiol (USP) <JP/US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Gastrointestinal Agents, Other
Ursodiol
D00734 Ursodiol (USP)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
23 Digestive organ agents
236 Cholagogues
2362 Bile acids
D00734 Ursodiol (USP); Ursodeoxycholic acid (JP18/INN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for digestive organs
11 Stomachics
D00734 Ursodiol (USP)
13 Digestives
D00734 Ursodiol (USP)
14 Two or more combinations from antacids, stomachics, digestives, and intestinal regulators
D00734 Ursodiol (USP)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
Ursodeoxycholic acid
D00734 Ursodiol (USP)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01956 Bile acid preparation
D00734 Ursodiol
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Liver X receptor like receptor
NR1H4 (FXR)
D00734 Ursodiol (USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00734 Ursodeoxycholic acid
D00734 Ursodeoxycholic acid tablets
D00734 Ursodeoxycholic acid granules